Gault Cheryl
Known title: Chief Operating OfficerCIK: 0001839046
Associated companies
Transaction History
| RAPP | ▼ Sell | Open Market | 7,925 | $262K | 9/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 2,075 | $70K | 9/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 1,900 | $76K | 6/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 3,792 | $157K | 6/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 3,308 | $140K | 6/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 1,000 | $43K | 6/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 7,161 | $201K | 3/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 2,839 | $81K | 3/30/2026 | View on chart |
| RAPP | ▼ Sell | Open Market | 2,014 | $58K | 3/5/2026 | View on chart |
| RAPP | ▲ Buy | Option Exercise | 5,000 | $9K | 11/26/2025 | View on chart |
| RAPP | ▼ Sell | Open Market | 5,000 | $150K | 11/26/2025 | View on chart |
| RAPP | ▲ Buy | Option Exercise | 5,000 | $9K | 9/8/2025 | View on chart |
| RAPP | ▼ Sell | Open Market | 5,000 | $192K | 9/8/2025 | View on chart |
| RAPP | ▲ Buy | Grant | 13,987 | $0 | 3/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Guggenheim initiates coverage of Rapport Therapeutics, sets $65 target
Guggenheim began coverage of Rapport Therapeutics and assigned a price target of $65. The target sits above the company's 52‑week high of $52.93, indicating a positive outlook. The stock currently trades with a low RSI and near a strong support level, which may influence market reaction to the new estimate.
Guggenheim initiates coverage of Rapport Therapeutics, sets $65 target. Guggenheim began coverage of Rapport Therapeutics and assigned a price target of $65. The target sits above the company's 52‑week high of $52.93, indicating a positive outlook. The stock currently trades with a low RSI and near a strong support level, which may influence market reaction to the new estimate.